Law 360 M&A

JANUARY 8, 2024

Swiss pharmaceutical giant Novartis is buying European company Calypso Biotech in a deal that could be worth up to $375 million, according to an announcement from Calypso on Monday, marking one of the earliest deals to be announced at the start of the deal frenzy expected at the J.P.

Start-ups 40

Start-ups 40

Benzinga

JUNE 28, 2023

Bobby Kotick , Activision Blizzard Inc 's (NASDAQ: ATVI ) CEO, said that the company would probably walk away from the $68.7 According to Bloomberg, Kotick made the statement during a federal court hearing in San Francisco on Wednesday, when he was testifying in favor of the deal. billion takeover bid by Microsoft Corp.

59

59

Law 360 M&A

JUNE 20, 2023

Pharmaceutical giant Eli Lilly & Co. on Tuesday announced that it has agreed to purchase San Francisco-based biopharmaceutical company Dice Therapeutics in a deal totaling roughly $2.4 billion and built by Kirkland & Ellis LLP and Fenwick & West LLP.

40

40

Reynolds Holding

MARCH 28, 2022

District Court in San Francisco denied a motion to dismiss charges filed by the Securities and Exchange Commission under an expansive new theory of insider trading liability. an oncology-focused biopharmaceutical company. Analyst reports also publicly listed Incyte among its peer companies. On January 14, 2022, the U.S.

Marketability 83

Marketability Banking Data Analysis Dividends 83